Thomas Betsy, Bellini Gabriele, Lee Wen-Yu, Shi Yidan, Mogilner Alon, Pourfar Michael H
Department of Neurology, NYU Langone Health, New York, USA.
Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, NYU Langone Health, New York, USA.
Tremor Other Hyperkinet Mov (N Y). 2025 May 5;15:18. doi: 10.5334/tohm.987. eCollection 2025.
High intensity focused ultrasound (HiFU) is a relatively new incisionless intervention used for treatment of essential tremor and Parkinson's disease tremor. Understanding the indications, benefits, risks and limitations of HiFU, as well as how it compares to deep brain stimulation (DBS), is important in guiding appropriate recommendations for prospective patients.
Current literature on efficacy and safety of HiFU in essential tremor and Parkinson's disease was reviewed. We additionally reviewed data on the patients who presented to our center for HiFU consultation, including outcomes of patients with low skull density ratios, and distances traveled for the procedure.
RESULTS/DISCUSSION: HiFU is an effective and generally well-tolerated treatment for tremor. Adverse events, especially gait instability, are typically temporary but should be discussed with patients. The risk of tremor recurrence in certain patients with Parkinson's disease is also of note. Identifying appropriate candidates for either intervention remains crucial and involves considering each patient's circumstances and preferences, potential adverse effects, and practical aspects like access to follow-up and expectations. Data on bilateral HiFU lesioning, use of HiFU in patients with low skull density ratios, and emerging targets like the pallidothalamic tract are discussed as well.
高强度聚焦超声(HiFU)是一种相对较新的无创干预手段,用于治疗特发性震颤和帕金森病震颤。了解HiFU的适应症、益处、风险和局限性,以及它与脑深部电刺激(DBS)相比如何,对于为潜在患者提供适当的建议至关重要。
回顾了关于HiFU治疗特发性震颤和帕金森病疗效及安全性的当前文献。我们还回顾了到我们中心进行HiFU咨询的患者的数据,包括颅骨密度比低的患者的结果以及手术的行程距离。
结果/讨论:HiFU是一种治疗震颤的有效且通常耐受性良好的方法。不良事件,尤其是步态不稳,通常是暂时的,但应与患者讨论。某些帕金森病患者震颤复发的风险也值得注意。确定适合任何一种干预的合适候选人仍然至关重要,这涉及考虑每个患者的情况和偏好、潜在的不良反应以及诸如随访机会和期望等实际问题。还讨论了双侧HiFU毁损、低颅骨密度比患者使用HiFU以及苍白球丘脑束等新兴靶点的数据。